These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 36404587)
1. Anti-virulence activity of novel (1-heteroaryloxy-2-hydroxypropyl)- phenylpiperazine derivatives against both wild-type and clinical drug-resistant Candida albicans strains. Huang J; Song S; Zhao S; Sun X; Wang Z; Huang X; Xiao Q; Deng Y Microb Biotechnol; 2023 Jan; 16(1):116-127. PubMed ID: 36404587 [TBL] [Abstract][Full Text] [Related]
2. (1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition. Zhao S; Huang JJ; Sun X; Huang X; Fu S; Yang L; Liu XW; He F; Deng Y Microb Biotechnol; 2018 Nov; 11(6):1080-1089. PubMed ID: 30221456 [TBL] [Abstract][Full Text] [Related]
3. Anti-virulence strategy of diaryl chalcogenide compounds against Song S; Zhao S; Sun X; Meng L; Wang Z; Tan H; Liu J; Zhang M; Deng Y Virulence; 2023 Dec; 14(1):2265012. PubMed ID: 37771181 [No Abstract] [Full Text] [Related]
5. Inhibition of Yeast-to-Hypha Transition and Virulence of Meng L; Zhao H; Zhao S; Sun X; Zhang M; Deng Y Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670437 [TBL] [Abstract][Full Text] [Related]
6. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence. Zhang M; Yan H; Lu M; Wang D; Sun S Int J Antimicrob Agents; 2020 Jan; 55(1):105804. PubMed ID: 31605727 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Compounds Isolated from Meng L; Sun C; Zhang C; Song S; Sun X; Ju J; Deng Y Mar Drugs; 2019 Jul; 17(8):. PubMed ID: 31357504 [No Abstract] [Full Text] [Related]
9. The novel antifungal agent AB-22 displays in vitro activity against hyphal growth and biofilm formation in Candida albicans and potency for treating systemic candidiasis. Lee KT; Lee DG; Choi JW; Park JH; Park KD; Lee JS; Bahn YS J Microbiol; 2022 Apr; 60(4):438-443. PubMed ID: 35286605 [TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of hypocrellin compounds and their synergistic effects with antimicrobial agents against Candida albicans. Song S; Sun X; Meng L; Wu Q; Wang K; Deng Y Microb Biotechnol; 2021 Mar; 14(2):430-443. PubMed ID: 32510867 [TBL] [Abstract][Full Text] [Related]
11. Metabolite profiling, antifungal, biofilm formation prevention and disruption of mature biofilm activities of Erythrina senegalensis stem bark extract against Candida albicans and Candida glabrata. Harley BK; Quagraine AM; Neglo D; Aggrey MO; Orman E; Mireku-Gyimah NA; Amengor CD; Jato J; Saaka Y; Fleischer TC PLoS One; 2022; 17(11):e0278096. PubMed ID: 36441750 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. Wong SS; Kao RY; Yuen KY; Wang Y; Yang D; Samaranayake LP; Seneviratne CJ PLoS One; 2014; 9(1):e85836. PubMed ID: 24465737 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of tetrazole derivatives bearing pyrrolidine scaffold and evaluation of their antifungal activity against Candida albicans. Łukowska-Chojnacka E; Kowalkowska A; Gizińska M; Koronkiewicz M; Staniszewska M Eur J Med Chem; 2019 Feb; 164():106-120. PubMed ID: 30594027 [TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin. Toutounji M; Tokajian S; Khalaf RA Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951 [TBL] [Abstract][Full Text] [Related]
15. Ke CL; Liao YT; Lin CH Virulence; 2021 Dec; 12(1):281-297. PubMed ID: 33427576 [No Abstract] [Full Text] [Related]
16. Antivirulence activity and in vivo efficacy of a thiazole derivative against candidiasis. Sá NP; Barros PP; Junqueira JC; Valério AD; Lino CI; Oliveira RB; Rosa CA; Johann S J Mycol Med; 2021 Jun; 31(2):101134. PubMed ID: 33862540 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition. Zhu B; Li Z; Yin H; Hu J; Xue Y; Zhang G; Zheng X; Chen W; Hu X Microbiol Spectr; 2022 Apr; 10(2):e0147821. PubMed ID: 35297651 [TBL] [Abstract][Full Text] [Related]
18. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Angiolella L; Stringaro AR; De Bernardis F; Posteraro B; Bonito M; Toccacieli L; Torosantucci A; Colone M; Sanguinetti M; Cassone A; Palamara AT Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350 [TBL] [Abstract][Full Text] [Related]
19. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model. Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932 [TBL] [Abstract][Full Text] [Related]
20. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375 [No Abstract] [Full Text] [Related] [Next] [New Search]